BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14752870)

  • 1. Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine.
    Müller L; Kramm CM; Tenenbaum T; Wessalowski R; Göbel U
    Pediatr Blood Cancer; 2004 Mar; 42(3):287-8. PubMed ID: 14752870
    [No Abstract]   [Full Text] [Related]  

  • 2. Vincristine induced unilateral ptosis.
    Dejan S; Dragana B; Ivana P; Borivoje B; Marko P
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):463. PubMed ID: 19648799
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy.
    Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F
    Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine-induced ptosis in a leukemia patient treated with pyridoxine and pyridostigmine.
    Johnson L; Johnson J; Philip SM; Thirugnanam R
    J Oncol Pharm Pract; 2023 Jul; 29(5):1271-1274. PubMed ID: 36734133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine induced cranial polyneuropathy.
    Bay A; Yilmaz C; Yilmaz N; Oner AF
    Indian J Pediatr; 2006 Jun; 73(6):531-3. PubMed ID: 16816519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].
    Berenguer-Potenciano M; Villora-Morcillo N; Nunez-Enamorado N; Perez-Alonso V; Camacho-Salas A; Simon-De Las Heras R
    Rev Neurol; 2015 Jan; 60(2):91-2. PubMed ID: 25583593
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy.
    Akbayram S; Akgun C; Doğan M; Sayin R; Caksen H; Oner AF
    Indian J Pediatr; 2010 Jun; 77(6):681-3. PubMed ID: 20532679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of botulinum toxin-induced eyelid ptosis with anticholinesterases.
    Karami M; Taheri A; Mansoori P
    Dermatol Surg; 2007 Nov; 33(11):1392-4 discussion 1394-5. PubMed ID: 17958599
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
    Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
    Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vincristine-Induced Neuropathy Presenting as Ptosis and Ophthalmoplegia in a 2-Year-Old Boy.
    Palkar AH; Nair AG; Desai RJ; Potdar NA; Shinde CA
    J Pediatr Ophthalmol Strabismus; 2015 Jul; 52 Online():e34-7. PubMed ID: 26176228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine induced cranial neuropathy.
    Dixit G; Dhingra A; Kaushal D
    J Assoc Physicians India; 2012 Mar; 60():56-8. PubMed ID: 22799120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vincristine-induced unilateral ptosis in a child.
    Gursel O; Sari E; Altun D; Atay AA; Akin R
    Pediatr Neurol; 2009 Dec; 41(6):461-3. PubMed ID: 19931172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vincristine-induced unilateral ptosis: case report and review of the literature].
    Batta B; Trechot F; Cloché V; George JL; Angioi K
    J Fr Ophtalmol; 2013 Oct; 36(8):683-6. PubMed ID: 23896211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood myasthenia gravis: clinical features and outcomes.
    Sri-udomkajorn S; Panichai P; Liumsuwan S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical therapy for oropharyngeal symptoms of myasthenia gravis.
    Dooley JM; Goulden KJ; Gatien JG; Gibson EJ; Brown BS
    Ann Neurol; 1986 Feb; 19(2):192-4. PubMed ID: 3963762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A myasthenic reaction provoked by lithium carbonate treatment].
    Voetmann C; Jerst P
    Ugeskr Laeger; 1978 Sep; 140(39):2375-6. PubMed ID: 695078
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluctuating weakness: clue in the eyes!
    Kaur A; Chaudhry C; Mehta A; Kaur A
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33372023
    [No Abstract]   [Full Text] [Related]  

  • 19. Childhood ocular myasthenia gravis.
    Kim JH; Hwang JM; Hwang YS; Kim KJ; Chae J
    Ophthalmology; 2003 Jul; 110(7):1458-62. PubMed ID: 12867410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular myasthenia].
    Huber A
    Klin Monbl Augenheilkd; 1985 Mar; 186(3):158-60. PubMed ID: 3999598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.